Aims & Scope

The journal CardioRenal Medicine explores the mechanisms by which obesity and other metabolic abnormalities promote the pathogenesis and progression of heart and kidney disease (cardiorenal metabolic syndrome).

It provides an interdisciplinary platform for the advancement of research and clinical practice, focussing on translational issues.

Attention is paid to the fact that some metabolic abnormalities cluster with heart and chronic kidney disease, and collectively this is called the cardiorenal metabolic syndrome.

Moreover, certain metabolic abnormalities of the heart promote impaired coronary artery endothelial function, diastolic dysfunction and ischemic reconditioning that parallel glomerular hyperfiltration and impairments in proximal tubule handling of sodium and albumin.

Another point of focus is the role of the obesity epidemic in promoting the increasing incidence of heart and kidney disease in industrialized countries and the prevailing problems of insufficient exercise and excessive consumption of cheap, unwholesome food in promotion of the cardiorenal metabolic syndrome in both adults and children.

CardioRenal Medicine addresses a multidisciplinary audience consisting of nephrologists, cardiologists, nutritionists, endocrinologists, physiologists and general internists.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 2.9
2024 2.40

SJR (SCImago Journal Rank)

Year Value
2024 0.723

Quartile

Year Value
2024 Q2

h-index

Year Value
2024 31

Journal Rank

Year Value
2024 7780

Journal Citation Indicator

Year Value
2024 251

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.


Quick Facts

Current Factor
2.9
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.723
First Published: 2024

Quartile

Current Quartile
Q2
First Published: 2024

Similar Journals

Top Journals in Related Fields